Olema Pharmaceuticals, Inc. OLMA Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

NXP SemiconductorsNXPI

$1M0.0%

Microchip TechnologyMCHP

$7.6M-42.4%

Lumentum Holdings Inc.LITE

$1.1M+37.5%

ON SemiconductorON

$2.9M0.0%

Devon EnergyDVN

$4M-33.3%

Extra Space StorageEXR

$12.56M+11.0%

Other financials

Income statement

See full

Operating income-$58.0M-66.3%

Net income-$53.1M-74.7%

EPS (diluted)-$0.52-44.4%

Balance sheet

See full

Cash & equivalents$52.5M+3.8%

Total debt$956.0K-16.7%

Total equity$480.5M+25.3%

Total assets$530.6M+29.5%

Cash flow

See full

Operating cash flow-$46.0M-4.6%

CapEx-—

Free cash flow-$34.5M-27.8%

Valuation

See full

Market cap$998.38M+253%

Enterprise value$946.79M+306%

Returns & leverage

See full

Return on equity-42.9%+1.3pp

Debt / equity0×0.0×

Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: Olema Pharmaceuticals, Inc.’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s amortization of debt discount premium?: Olema Pharmaceuticals, Inc. (OLMA) reported amortization of debt discount premium of -$1.57M in Q4 2025.
How has Olema Pharmaceuticals, Inc.'s amortization of debt discount premium changed year-over-year?: Olema Pharmaceuticals, Inc.'s amortization of debt discount premium increased by 23.0% year-over-year, from -$2.04M to -$1.57M.